DeepMed Research

Rogel Cancer Center: University of Michigan

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1991-01-01

Employees: -

Market Cap: -

Website: http://www.rogelcancercenter.org

Clinical Trials

A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Radiation: Liver Irradiation

First Posted Date: 2012-01-26

Last Posted Date: 2015-05-18

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 23

Registration Number: NCT01519232

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: Veliparib
Radiation: Standard radiation treatment

First Posted Date: 2011-11-22

Last Posted Date: 2017-12-15

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 33

Registration Number: NCT01477489

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Axitinib (AG-013736)

First Posted Date: 2011-11-10

Last Posted Date: 2016-08-29

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 42

Registration Number: NCT01469546

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Phase 2

Completed

Conditions: Acute Myeloblastic Leukemia

Interventions: Drug: Clofarabine/Busulfan x 4
Procedure: Peripheral blood stem cell transplant

First Posted Date: 2011-10-24

Last Posted Date: 2017-06-02

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 75

Registration Number: NCT01457885

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
University of Alabama, Birmingham, Birmingham, Alabama, United States
🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States

and more 9 locations

Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone

Phase 2

Terminated

Conditions: Prostate Cancer Metastatic

Interventions: Drug: Cabozantinib

First Posted Date: 2011-09-02

Last Posted Date: 2017-12-12

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 25

Registration Number: NCT01428219

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer

Terminated

Conditions: Non-Small Cell Lung Cancer

First Posted Date: 2011-08-04

Last Posted Date: 2014-03-31

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 41

Registration Number: NCT01409681

Locations: 🇺🇸
United States Department of Veteran's Affairs Medical Center, Ann Arbor, Michigan, United States
🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States

Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma

Phase 2

Terminated

Conditions: Follicular Lymphoma

Interventions: Drug: Bexxar
Drug: Low Dose Methotrexate

First Posted Date: 2011-07-07

Last Posted Date: 2017-01-30

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 22

Registration Number: NCT01389076

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

Hypofractionated Stereotactic Body Radiation Therapy (SBRT)

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Radiation: Radiation Therapy

First Posted Date: 2011-02-02

Last Posted Date: 2017-10-24

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 68

Registration Number: NCT01288534

Locations: 🇺🇸
The Radiological Associates of Sacremento, Sacramento, California, United States
🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States

A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck

Phase 2

Terminated

Conditions: Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Interventions: Drug: AT-101
Drug: Docetaxel

First Posted Date: 2011-01-28

Last Posted Date: 2016-03-31

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 35

Registration Number: NCT01285635

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion

Completed

Conditions: Liver Cancer

First Posted Date: 2010-09-28

Last Posted Date: 2024-12-05

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 143

Registration Number: NCT01210027

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy